Search Results - T. Richard Nichols
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
-
3
8 Rapid Spinal Mechanisms of Motor Coordination by T. Richard Nichols, Timothy C. Cope, Thomas A. Abelew
Published 1999Revisão -
4
-
5
-
6
-
7
-
8
Safety and Immunogenicity of Increasing Doses of a <i>Clostridium difficile</i> Toxoid Vaccine Administered to Healthy Adults by Karen L. Kotloff, Steven S. Wasserman, Genevieve A. Losonsky, William D. Thomas, Richard Nichols, Robert Edelman, Margaret W. Bridwell, Thomas P. Monath
Published 2001Artigo -
9
Immunization of Mice with Urease Vaccine Affords Protection against <i>Helicobacter pylori</i> Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted Res... by Thomas H. Ermak, Paul J. Giannasca, Richard Nichols, Gwendolyn A. Myers, John G. Nedrud, Richard Weltzin, Cynthia Lee, Harold Kleanthous, Thomas P. Monath
Published 1998Artigo -
10
Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial. by Thomas P. Monath, Richard Nichols, W. Tad Archambault, Linda W. Moore, Ron Marchesani, Jason Tian, Robert E. Shope, Nicola Thomas, Robert Schrader, Dean Furby, Philip Bedford
Published 2002Artigo -
11
Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys by Thomas P. Monath, Inessa S. Levenbook, Kenneth F. Soike, Z.-X. Zhang, Marion S. Ratterree, Ken Draper, Alan D.T. Barrett, Richard Nichols, Richard Weltzin, Juan Arroyo, Farshad Guirakhoo
Published 2000Artigo -
12
Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults by Scott A. Halperin, Rituparna Das, Matthew Onorato, Kenneth Liu, Jason Martin, Rebecca J. Grant-Klein, Richard Nichols, Beth-Ann Coller, F.A. Helmond, Jakub K. Simon
Published 2019Artigo -
13
ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defense by Thomas P. Monath, Joseph R. Caldwell, Wolfgang Mundt, Joan Fusco, Casey Johnson, Mark Buller, Jian Liu, Bridget Gardner, Greg Downing, Paul S. Blum, Tracy Kemp, Richard Nichols, Richard Weltzin
Published 2004Revisão -
14
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines by Heiko Ilchmann, Nathaly Samy, Daniela Reichhardt, Darja Schmidt, Jacqueline D Powell, Thomas P.H. Meyer, Günter Silbernagl, Richard Nichols, Heinz Weidenthaler, Laurence De Moerlooze, Liddy Chen, Paul Chaplin
Published 2022Artigo -
15
Rectal and Intranasal Immunizations with Recombinant Urease Induce Distinct Local and Serum Immune Responses in Mice and Protect against <i>Helicobacter pylori</i> Infection by Harry Kleanthous, Gwendolyn A. Myers, K. Georgakopoulos, Timothy Tibbitts, Jennifer W. Ingrassia, Heather Gray, Ru Ding, Zhen-Zi Zhang, Wen-de Lei, Richard Nichols, Cynthia Lee, Thomas H. Ermak, Thomas P. Monath
Published 1998Artigo -
16
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Derma... by Richard N. Greenberg, Yadira Hurley, Dinh V. Dinh, Serena Mraz, Javier Gómez Vera, Dorothea von Bredow, Alfred von Krempelhuber, Siegfried Röesch, Garth Virgin, Nathaly Arndtz-Wiedemann, Thomas Meyer, Darja Schmidt, Richard Nichols, Philip Young, Paul Chaplin
Published 2015Artigo -
17
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/be... by Thomas P. Monath, Patricia Fast, Kayvon Modjarrad, David K. Clarke, Brian K. Martin, Joan Fusco, Richard Nichols, D. Gray Heppner, Jakub K. Simon, Sheri Dubey, Sean P. Troth, Jayanthi Wolf, Vidisha Singh, Beth-Ann Coller, James S. Robertson
Published 2019Artigo -
18
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults by Pierre Michetti, Christianna Kreiss, Karen L. Kotloff, Nadine Porta, J Blanco, Daniel Bachmann, Maribelle Herranz, Pierre F. Saldinger, Irène Corthésy–Theulaz, Genevieve A. Losonsky, Richard Nichols, Joseph Simon, Manfred Stolte, Samuel Ackerman, Thomas P. Monath, A. L. Blum
Published 1999Artigo -
19
A live, attenuated recombinant West Nile virus vaccine by Thomas P. Monath, Jian Liu, Niranjan Kanesa-thasan, Gwendolyn A. Myers, Richard Nichols, Alison Deary, Karen McCarthy, Casey Johnson, Thomas H. Ermak, Sunheang Shin, Juan Arroyo, Farshad Guirakhoo, Jeffrey S. Kennedy, Francis A. Ennis, Sharone Green, Philip Bedford
Published 2006Artigo -
20
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old S... by Richard N. Greenberg, Christine M. Hay, Jack T. Stapleton, Thomas Marbury, Eva Wagner, Eva Kreitmeir, Siegfried Röesch, Alfred von Krempelhuber, Philip Young, Richard Nichols, Thomas P.H. Meyer, Darja Schmidt, Josef Weigl, Garth Virgin, Nathaly Arndtz-Wiedemann, Paul Chaplin
Published 2016Artigo
Search Tools:
Related Subjects
Immunology
Medicine
Antibody
Virology
Biology
Immunogenicity
Vaccination
Virus
Gene
Biochemistry
Internal medicine
Recombinant DNA
Adverse effect
Yellow fever
Immune system
Immunization
Smallpox vaccine
Titer
Vaccinia
Alternative medicine
Genetics
Microbiology
Modified vaccinia Ankara
Pathology
Physics
Placebo
Attenuated vaccine
Ebola vaccine
Ebola virus
Environmental health